17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 3, 2009
Grant Date -
Jan 3, 2008
app pub date -
Aug 9, 2007
filing date -
Dec 17, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with type 3 17β-hydroxysteroid dehydrogenase using such compounds or pharmaceutical compositions.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully